leucine has been researched along with maraviroc in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
AlAjmi, MF; Anwar, S; Hassan, MI; Hussain, A; Islam, A; Mohammad, T; Rehman, MT; Shamsi, A | 1 |
1 other study(ies) available for leucine and maraviroc
Article | Year |
---|---|
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy.
Topics: Aminoisobutyric Acids; Antiviral Agents; Betacoronavirus; Computer Simulation; Cyclopropanes; Drug Evaluation, Preclinical; Lactams, Macrocyclic; Leucine; Maraviroc; Molecular Structure; Proline; Protease Inhibitors; Quinoxalines; SARS-CoV-2; Sulfonamides | 2020 |